Maven Securities LTD Dyne Therapeutics, Inc. Transaction History

Maven Securities LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $570,897 - $785,350	-36,596 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $876,158 - $1.23 Million	-54,966 Reduced 60.03%	36,596 $798,000
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $1.28 Million - $2.68 Million	91,562 New	91,562 $1.39 Million
Q4 2020 Feb 12, 2021	SELL	$16.81 - $23.94 $178,186 - $253,764	-10,600 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$20.0 - $23.9 $212,000 - $253,339	10,600 New	10,600 $212,000

176

87.1M

130K

209K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.78B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.